article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law Blog

District Court for the Western District of Texas imposed a $275,000 civil penalty on Zarzamora Healthcare LLC, in San Antonio, and its pharmacist-owner. The government asserted additional allegations that are outside our scope. On October 10th, based on ability to pay, the U.S. 11, 2023 ( DOJ Press Release ). Zarzamora Press Release.

article thumbnail

Risking It All For a New Business Model at Family Physicians of St. Joe

Family Physicians of St. Joseph

Written by Pat Moody on Moody on the Market When it comes to healthcare, and primary care in particular, it has become increasingly difficult to remain successful as a small, independent practice. The good doctors say that to state that stepping outside of the traditional box of healthcare has been challenging would be an understatement.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biogen agrees to pay $900 million in largest FCA Settlement Ever Secured without Government’s Intervention

FDA Law Blog

Department of Health and Human Services (HHS) and the Department of Justice (DOJ) have aggressively pursued antikickback cases in the healthcare industry. The Alert described several factors that could potentially violate the antikickback statute.

article thumbnail

FDA Publishes Discussion Paper Seeking Feedback on 3D Printing of Medical Devices at the Point of Care

FDA Law Blog

This discussion paper is not the first time that FDA has grappled with the tricky regulatory questions presented by 3D printing. Rather, it is meant to present various scenarios related to use of 3D?printed The first scenario is a healthcare facility using a medical device 3D-printing production system.

Medical 98
article thumbnail

FDA Publishes Discussion Paper Seeking Feedback on 3D Printing of Medical Devices at the Point of Care

FDA Law Blog

This discussion paper is not the first time that FDA has grappled with the tricky regulatory questions presented by 3D printing. Rather, it is meant to present various scenarios related to use of 3D?printed The first scenario is a healthcare facility using a medical device 3D-printing production system.

Medical 75
article thumbnail

A patient’s perspective: The evolving landscape of IBD

ABIM

This burden of the disease is being felt by patients and healthcare providers. Specific Challenges in IBD Care Even in a country with advanced healthcare, living with IBD in the U.S. Despite living in Southern California, with what many would consider strong access to healthcare, I went undiagnosed for over five years.

article thumbnail

Screening for Dementia: A Podcast with Anna Chodos, Joseph Gaugler and Soo Borson

GeriPal

So I think we’re poised now with the guide model and with the evidence we have about healthcare utilization, impact on caregivers, course of dementia, comorbidity management and all of that. I don’t have access to change the levers of government. Eric 19:56 Okay, but I’m a primary care provider. But I don’t.

Screening 119